Sunesis upgraded to Outperform at Oppenheimer
Last sunesis pharmaceuticals, inc earnings: 3/10 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations: ir.sunesis.com/investor-overview
| Impact snapshot | Event time: | SNSS | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last price | ||
| VWAP | ||
|
High:
|
Max up |
High:
|
|
Low:
|
Max down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event Day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance Since Event
Time and Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
SIGN UP TODAY
Opt-in for
SNSS alerts
SNSS alerts
from News Quantified
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SNSS alerts
High impacting Sunesis Pharmaceuticals, Inc news events
Weekly update
A roundup of the hottest topics
SNSS
News
- Sunesis Pharmaceuticals, Inc. (<a href="https://www.marketbeat.com/stocks/NASDAQ/SNSS/price-target/">NASDAQ: SNSS</a>) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating.MarketBeat
- Viracta Therapeutics Announces Closing of Merger with Sunesis Pharmaceuticals and $65M Private PlacementPR Newswire
- Sunesis Pharmaceuticals, Inc. (<a href="https://www.marketbeat.com/stocks/NASDAQ/SNSS/price-target/">NASDAQ: SNSS</a>) was upgraded by analysts at Oppenheimer Holdings Inc. from a "market perform" rating to an "outperform" rating. They nMarketBeat
- Viracta Therapeutics Announces Notice of Allowance for U.S. Patent Application Covering the Use of its Combination Product Candidate for the Treatment of Epstein-Barr Virus-associated LymphomaPR Newswire
- Viracta Therapeutics to Participate in Upcoming Virtual Investor ConferencesPR Newswire
- More
SNSS
SEC Filings
- 2/25/21 - Form 3
- 2/25/21 - Form 3
- 2/24/21 - Form 3
- SNSS's page on the SEC website
- More